Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2011

Jan 26, 2011

34519_dirs_2011-01-26_25e449bd-d2a5-4d3a-b29f-db9850899ec0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2011-01-24

Reporting Person: Rhodes Linda (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-01-24 Common stock, $0.10 par value P 200 $3.00 Acquired 3600 Direct